Gemcabene ( DrugBank: Gemcabene )

---

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
79	家族性高コレステロール血症（ホモ接合体）	1
265	脂肪萎縮症	1

79. 家族性高コレステロール血症（ホモ接合体）

---

臨床試験数 : 142 /  薬物数 : 114 - (DrugBank : 29) / 標的遺伝子数 : 9 - 標的パスウェイ数 : 18

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02722408 (ClinicalTrials.gov)	June 2016	12/3/2016	Efficacy and Safety of Gemcabene in Patients With Homozygous Familial Hypercholesterolemia on Stable, Lipid-Lowering Therapy (COBALT-1)	A Phase 2 Open-Label, Dose-Finding Study to Assess the Efficacy, Safety, and Tolerability of Gemcabene in Patients With Homozygous Familial Hypercholesterolemia on Stable, Lipid Lowering Therapy (COBALT-1)	Hypercholesteremia	Drug: Gemcabene	NeuroBo Pharmaceuticals Inc.	NULL	Completed	17 Years	N/A	All	8	Phase 2	United States;Canada;Israel

265. 脂肪萎縮症

---

臨床試験数 : 116 /  薬物数 : 170 - (DrugBank : 61) / 標的遺伝子数 : 26 - 標的パスウェイ数 : 97

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03508687 (ClinicalTrials.gov)	March 13, 2018	3/4/2018	Study of Gemcabene in Adults With FPLD	An Investigator-Initiated Open-Label, Randomized Study of Gemcabene in Adults With Familial Partial Lipodystrophy Disease (FPLD)	Familial Partial Lipodystrophy;Hypertriglyceridemia;Fatty Liver;NASH - Nonalcoholic Steatohepatitis	Drug: 300mg Gemcabene;Drug: 600mg Gemcabene	Elif Oral	NULL	Completed	18 Years	N/A	All	5	Phase 1/Phase 2	United States